KSC:005690
Pharmicell Co., Ltd. · KSC · Healthcare · KRW · FY for 2025
Figures on this page computed 2026-11-08 12:57 UTC
Last close
n/aKRW
Market data
11.8xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
35.4%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
29.5%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
0.12Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- KRW
- computed
6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
Then and now
lens 3 of 9| Fact | 2014 | 2025 | Change |
|---|---|---|---|
| Sales | 20,155,408,360 | 114,061,538,000 | +466% |
| Profit | -28,768,437,020 | 40,329,514,000 | +240% |
| Free cash flow | -11,179,524,770 | 33,601,600,000 | +401% |
| Debt | 8,992,167,000 | 14,586,566,000 | +62.2% |
| Shares in issue | 46,475,666 | 60,017,000 | +29.1% |
The same five facts for 2014 and 2025, each read from the year's own filing.
The same five facts for 2014 and 2025, each read from the year's own filing.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2014
Sales, 201420,155,408,360
- Source
- computed
- Statement
- income
- Fiscal year
- 2014
- Reported in
- KRW
Sales, 2025114,061,538,000Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Profit, 2014-28,768,437,020
- Source
- computed
- Statement
- income
- Fiscal year
- 2014
- Reported in
- KRW
Profit, 202540,329,514,000Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Free cash flow, 2014-11,179,524,770
- Source
- computed
- Statement
- income
- Fiscal year
- 2014
- Reported in
- KRW
Free cash flow, 202533,601,600,000Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Debt, 20148,992,167,000
- Source
- computed
- Statement
- income
- Fiscal year
- 2014
- Reported in
- KRW
Debt, 202514,586,566,000Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW
Shares in issue, 201446,475,666
- Source
- computed
- Statement
- income
- Fiscal year
- 2014
- Reported in
- KRW
Shares in issue, 202560,017,000Computed from the filing for 2025
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- KRW